论文部分内容阅读
目的探讨经痛愈舒颗粒治疗子宫内膜异位症的临床疗效。方法随机选取2014年3月至2014年9月72例子宫内膜异位症患者为研究对象,随机分为实验组和对照组,每组36例;对照组予以孕三烯酮口服药物治疗,2.5 mg/次、2次/周,连续用药一个疗程;实验组予以经痛愈舒颗粒口服冲剂治疗,温水冲服,100 ml/次、2次/d,连续用药一疗程。停药后记录两组患者症状、体征及B超检查结果。结果治疗后实验组痊愈率(16.67%)高于对照组(5.56%);实验组显效率(50.00%)高于对照组(33.33%);实验组有效率(30.56%)高于对照组(38.89%);实验组无效率(2.78%)低于对照组(22.22%);实验组总有效率(97.22%)显著高于对照组(77.78%),差异有统计学意义(P<0.05)。结论经痛愈舒颗粒治疗子宫内膜异位症的临床疗效显著优于孕三烯酮,值得临床广泛应用与推广。
Objective To investigate the clinical efficacy of Jugong Yushu Granule in the treatment of endometriosis. Methods A total of 72 patients with endometriosis from March 2014 to September 2014 were randomly divided into experimental group and control group, with 36 cases in each group. The control group received gestrinone oral drug treatment, 2.5 mg / time, 2 times / week, continuous medication for a course of treatment; experimental group to be treated by pain and more Shu granules oral granules, warm water, 100 ml / time, 2 times / d, continuous medication for a course of treatment. After stopping the two groups of patients were recorded symptoms, signs and B-test results. Results The cure rate (16.67%) in the experimental group was significantly higher than that in the control group (5.56%). The effective rate (50.00%) in the experimental group was significantly higher than that in the control group (33.33% 38.89%). The total effective rate (97.22%) in the experimental group was significantly higher than that in the control group (77.78%), the difference was statistically significant (2.78% . Conclusion The clinical curative effect of Jingtong Yushu Granule in treatment of endometriosis is significantly better than gestrinone, which deserves wide application and promotion in clinic.